smallpox vaccine LC16m8: Clinical Trials

3 trials of smallpox vaccine LC16m8, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 recruiting, 1 unknown. 1 Phase 1, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 11Unknown 1
Phase 21Unknown 1
Phase 31Active not recruiting 1

Follow smallpox vaccine LC16m8: new trials by email Literature Review of smallpox vaccine LC16m8 trials Research Report on smallpox vaccine LC16m8

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of Effectiveness and Safety of LC16m8 Mpox Vaccine in the Democratic Republic of Congo (DRC)
LC16m8 - Mpox (Monkeypox), Mpox
RecruitingInternational Vaccine Institute119902025-12-032026-08-31
Efficacy/Effectiveness, Safety, and Immunogenicity of LC16m8 Mpox Vaccine in Colombia
LC16m8 - Monkeypox
Phase 3Active not recruitingUniversidad Nacional de Colombia86862023-12-162025-09-04
Safety and Immunogenicity Study of LC16m8, a Modified Smallpox Vaccine, in Healthy, Previously Unvaccinated Volunteers
LC16m8 Smallpox Vaccine - Smallpox
Phase 1 / Phase 2UnknownVaxGen1502004-10-012007-01-15

Conditions studied

Mpox, Monkeypox (2)  ·  Smallpox (1)

Sponsors

International Vaccine Institute (1)  ·  Universidad Nacional de Colombia (1)  ·  VaxGen (1)

Countries

Colombia (1)  ·  Democratic Republic of the Congo (1)  ·  United States (1)

Top investigators

Florian Marks (1)  ·  Jean Jacques Muyembe (1)  ·  Marc Gurwith, MD, JD (1)  ·  Norio Ohmagari (1)

Results publications

PMID 21921208